article thumbnail

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT

At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary guidance allowing traditional compounding pharmacies, within tight regulatory guardrails, to prepare 13 Covid drugs from pure ingredients to meet hospitals’ urgent need.

article thumbnail

STAT+: Pharmalittle: We’re reading about Pfizer struggles with Starboard, Lilly going after compounders, and more

STAT

in 2022 and 66% in 2021. As the proportion of industry-bound researchers dipped in 2023, the percentage of graduates going into academic jobs increased from 18.8% in 2022 to 22.1%. But more granular data provided by NSF showed that, in 2023, about 75% of these jobs were non-tenure track positions, compared to 70.6%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Summer 2021 – Transforming Pharmacy Through Innovation and Superior Customer Experience

Omnicell

Today, we announced our Summer 2021 Release, which delivers enhancements across our entire portfolio designed to improve efficiency, expand automation, and enhance intelligence, supported through a superior customer experience, driving maximum value sooner for your technology investment. Learn more about these latest innovations here.

article thumbnail

Top Performing Drug of 2021 - Trulicity (February Edition)

PharmaShots

In 2021, the revenue of Trulicity increased by 28% in the U.S., In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026). Active Ingredient: dulaglutide Dosage Forms & Strengths: Injection: 0.75 mL, 3 mg/0.5 It is one of the key growth products of Eli Lilly.

article thumbnail

STAT+: Roivant autoimmune drug succeeds in eye condition; company to buy back $1.5 billion in stock

STAT

The autoimmune drug, brepocitinib, is being steered by a company called Priovant Therapeutics, which was formed as part of a deal between Roivant and Pfizer in 2021.     It is one of the most-watched compounds in Roivant’s pipeline for multiple autoimmune indications. Continue to STAT+ to read the full story…

article thumbnail

AI Driven Repositioning and Repurposing Summit 2021

pharmaphorum

Given these circumstances, drug repositioning and repurposing has appeared as an alternative tool to accelerate drug development processes by seeking new indications for approved/shelved drugs rather than discovering de novo drug compounds. The post AI Driven Repositioning and Repurposing Summit 2021 appeared first on.

article thumbnail

Opinion: Policymakers must take action on the physician shortage

STAT

These workforce challenges are compounded by the fact that America — both physicians  and our patient population — is also aging, and the number of available doctors is shrinking. Nearly 334,000  health care professionals left the workforce in 2021.